Latest Innovation News

Vonex Limited has terminated its proposed scheme with Maxo Telecommunications amid shareholder opposition, while MaxoTel’s 4.4c cash offer will close on January 28, 2025. The Vonex Board recommends shareholders accept MaxoTel’s offer and reject Swoop Telecommunications’ conditional scrip bid.

RLF AgTech has secured a strategic trading agreement with National Rural Independent Ltd, enabling distribution of its crop nutrition products through 152 stores nationwide, marking a pivotal step in its Australian market expansion.

Connexion Mobility reports robust Q2 FY25 results with revenue and net profit surging, driven by subscription growth and strategic product launches. The company’s focus on user engagement and marketplace expansion signals promising long-term shareholder value.

RLF AgTech has secured a strategic trading agreement with National Rural Independent Ltd, enabling distribution of its crop nutrition products through 152 NRI stores nationwide. This partnership aims to boost RLF’s Australian market presence and support sustainable farming practices.

Dimerix has reached a key milestone by enrolling the first paediatric patient aged 12-17 in its ACTION3 Phase 3 trial for DMX-200, advancing its potential treatment for childhood FSGS kidney disease.

4DS Memory Limited has completed critical testing on its Fifth Platform Lot, paving the way for manufacturing a 20nm memory cell array in the upcoming Sixth Platform Lot. This milestone could position 4DS’s ReRAM technology as a next-generation memory solution.

Orthocell Limited has reported a third consecutive quarter of record revenue, driven by strong sales growth and strategic market expansions, including a key US FDA submission for its nerve repair product Remplir™.

PWR Holdings' North American arm, C&R Racing Inc., has landed a $8.9 million AUD order to supply advanced cooling systems for a US government aerospace project, marking a pivotal milestone in its defence sector expansion.

Advance ZincTek reports steady profit before tax for H1 FY25, driven by strong North American growth and significant cost savings following its Perth facility closure.

HITIQ Limited has received $1.6 million from the R&D Tax Incentive Scheme, using most of it to repay its RDTI Facility with Keystone Capital Partners, signaling a strategic move to streamline its R&D funding.

Mesoblast has raised A$260 million through a global private placement to fund the US commercial launch of its FDA-approved cell therapy Ryoncil® and accelerate clinical development in chronic low back pain.

Telix Pharmaceuticals has exceeded its full-year 2024 revenue guidance, driven by strong sales of its prostate cancer diagnostic Illuccix® and strategic pipeline advancements.